ImportRefusal LogoImportRefusal

Niagara Pharmaceuticals Inc

⚠️ Moderate Risk

FEI: 3003093882 • Dundas, Ontario • CANADA

FEI

FEI Number

3003093882

📍

Location

Dundas, Ontario

🇨🇦

Country

CANADA
🏢

Address

60 Innovation Dr, , Dundas, Ontario, Canada

Moderate Risk

FDA Import Risk Assessment

48.0
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

15
Total Refusals
5
Unique Violations
2/8/2011
Latest Refusal
4/9/2007
Earliest Refusal

Score Breakdown

Violation Severity
76.9×40%
Refusal Volume
44.6×30%
Recency
0.0×20%
Frequency
39.1×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

7515×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1611×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

3331×

LACKS FIRM

The article is in package form and appears to not bear a label containing the name and place of business of the manufacturer, packer, or distributor.

3351×

LACKS N/C

The article is in package form and appears to not have a label containing an accurate statement of the quantity of the contents in terms of weight, measure or numerical count and no variations or exemptions have been prescribed by regs.

Refusal History

DateProductViolationsDivision
2/8/2011
79LRRKIT, FIRST AID
75UNAPPROVED
Seattle District Office (SEA-DO)
11/1/2010
55RP70BORIC ACID (PHARMACEUTIC NECESSITY)
75UNAPPROVED
New York District Office (NYK-DO)
11/13/2008
64WBL99IRRIGATION SOLUTION N.E.C.
75UNAPPROVED
New York District Office (NYK-DO)
6/18/2007
64WAK99IRRIGATION SOLUTION N.E.C.
16DIRECTIONS
75UNAPPROVED
Detroit District Office (DET-DO)
6/18/2007
64WAK99IRRIGATION SOLUTION N.E.C.
16DIRECTIONS
75UNAPPROVED
Detroit District Office (DET-DO)
6/18/2007
64WAK99IRRIGATION SOLUTION N.E.C.
16DIRECTIONS
75UNAPPROVED
Detroit District Office (DET-DO)
6/18/2007
64WAK99IRRIGATION SOLUTION N.E.C.
16DIRECTIONS
75UNAPPROVED
Detroit District Office (DET-DO)
6/18/2007
64WAK99IRRIGATION SOLUTION N.E.C.
16DIRECTIONS
75UNAPPROVED
Detroit District Office (DET-DO)
6/18/2007
64WAK99IRRIGATION SOLUTION N.E.C.
16DIRECTIONS
75UNAPPROVED
Detroit District Office (DET-DO)
6/18/2007
55RG70BORIC ACID (PHARMACEUTIC NECESSITY)
16DIRECTIONS
75UNAPPROVED
Detroit District Office (DET-DO)
6/18/2007
55RG70BORIC ACID (PHARMACEUTIC NECESSITY)
16DIRECTIONS
75UNAPPROVED
Detroit District Office (DET-DO)
6/18/2007
55RG70BORIC ACID (PHARMACEUTIC NECESSITY)
16DIRECTIONS
75UNAPPROVED
Detroit District Office (DET-DO)
6/18/2007
64WAK99IRRIGATION SOLUTION N.E.C.
16DIRECTIONS
75UNAPPROVED
Detroit District Office (DET-DO)
5/10/2007
55RP70BORIC ACID (PHARMACEUTIC NECESSITY)
118NOT LISTED
333LACKS FIRM
335LACKS N/C
75UNAPPROVED
New York District Office (NYK-DO)
4/9/2007
64WAK99IRRIGATION SOLUTION N.E.C.
16DIRECTIONS
75UNAPPROVED
Detroit District Office (DET-DO)

Frequently Asked Questions

What is Niagara Pharmaceuticals Inc's FDA import refusal history?

Niagara Pharmaceuticals Inc (FEI: 3003093882) has 15 FDA import refusal record(s) in our database, spanning from 4/9/2007 to 2/8/2011.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Niagara Pharmaceuticals Inc's FEI number is 3003093882.

What types of violations has Niagara Pharmaceuticals Inc received?

Niagara Pharmaceuticals Inc has been cited for 5 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Niagara Pharmaceuticals Inc come from?

All FDA import refusal data for Niagara Pharmaceuticals Inc is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.